<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Neuronal ceroid lipofuscinosis - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Neuronal_ceroid_lipofuscinosis#Forms" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Neuronal_ceroid_lipofuscinosis" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Neuronal_ceroid_lipofuscinosis#Forms" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Neuronal_ceroid_lipofuscinosis","wgTitle":"Neuronal ceroid lipofuscinosis","wgCurRevisionId":667672442,"wgRevisionId":667672442,"wgArticleId":2187652,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","CS1 Norwegian-language sources (no)","Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from November 2008","Articles that use a Medicine navs subtemplate","Lipid storage disorders","Rare diseases","Autosomal recessive disorders"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Neuronal_ceroid_lipofuscinosis","wgRelevantArticleId":2187652,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Ceroid_lipofuscinois,_neuronal_6,_late_infantile","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Neuronal_ceroid_lipofuscinosis#Forms","wgWikibaseItemId":"Q4358039"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Neuronal_ceroid_lipofuscinosis skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Neuronal ceroid lipofuscinosis</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Ceroid_lipofuscinois,_neuronal_6,_late_infantile&amp;redirect=no" title="Ceroid lipofuscinois, neuronal 6, late infantile">Ceroid lipofuscinois, neuronal 6, late infantile</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Neuronal ceroid lipofuscinosis</th>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E75.4">E75.4</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=330.1">330.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/001613.htm">001613</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic498.htm">neuro/498</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D009472">D009472</a></td>
</tr>
</table>
<p><b>Neuronal ceroid lipofuscinoses</b> (<b>NCL</b>) is the general name for a <a href="/wiki/Family" title="Family">family</a> of at least eight genetically separate <a href="/wiki/Neurodegenerative_disorder" title="Neurodegenerative disorder" class="mw-redirect">neurodegenerative disorders</a> that result from excessive accumulation of lipopigments (<a href="/wiki/Lipofuscin" title="Lipofuscin">lipofuscin</a>) in the body's tissues. These lipopigments are made up of fats and <a href="/wiki/Proteins" title="Proteins" class="mw-redirect">proteins</a>. Their name comes from the word stem <i>lipo-</i>, which is a variation on "<a href="/wiki/Lipid" title="Lipid">lipid</a>" or "fat", and from the term <i>pigment</i>, used because the substances take on a greenish-yellow color when viewed under an ultraviolet light microscope. These lipofuscin materials build up in neuronal cells and many organs, including the <a href="/wiki/Liver" title="Liver">liver</a>, <a href="/wiki/Spleen" title="Spleen">spleen</a>, <a href="/wiki/Myocardium" title="Myocardium" class="mw-redirect">myocardium</a>, and kidneys.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#General_characteristics"><span class="tocnumber">1</span> <span class="toctext">General characteristics</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#History"><span class="tocnumber">2</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#19th_century"><span class="tocnumber">2.1</span> <span class="toctext">19th century</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#1900_to_1950"><span class="tocnumber">2.2</span> <span class="toctext">1900 to 1950</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#1950_to_today"><span class="tocnumber">2.3</span> <span class="toctext">1950 to today</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Forms"><span class="tocnumber">3</span> <span class="toctext">Forms</span></a>
<ul>
<li class="toclevel-2 tocsection-7"><a href="#Mutations"><span class="tocnumber">3.1</span> <span class="toctext">Mutations</span></a>
<ul>
<li class="toclevel-3 tocsection-8"><a href="#Infantile_form"><span class="tocnumber">3.1.1</span> <span class="toctext">Infantile form</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Late_infantile_form"><span class="tocnumber">3.1.2</span> <span class="toctext">Late infantile form</span></a></li>
<li class="toclevel-3 tocsection-10"><a href="#Juvenile_form"><span class="tocnumber">3.1.3</span> <span class="toctext">Juvenile form</span></a></li>
<li class="toclevel-3 tocsection-11"><a href="#Adult_dominant_form"><span class="tocnumber">3.1.4</span> <span class="toctext">Adult dominant form</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Incidence"><span class="tocnumber">4</span> <span class="toctext">Incidence</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Inheritance"><span class="tocnumber">5</span> <span class="toctext">Inheritance</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Diagnosis"><span class="tocnumber">6</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Treatment"><span class="tocnumber">7</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Cystagon"><span class="tocnumber">7.1</span> <span class="toctext">Cystagon</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Gene_therapy"><span class="tocnumber">7.2</span> <span class="toctext">Gene therapy</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Flupirtine"><span class="tocnumber">7.3</span> <span class="toctext">Flupirtine</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Stem_cells"><span class="tocnumber">7.4</span> <span class="toctext">Stem cells</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Immunosuppressants"><span class="tocnumber">7.5</span> <span class="toctext">Immunosuppressants</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-21"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="General_characteristics">General characteristics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=1" title="Edit section: General characteristics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The classic characterization of the group of neurodegenerative, <a href="/wiki/Lysosomal_storage_disorders" title="Lysosomal storage disorders" class="mw-redirect">lysosomal storage disorders</a> called the neuronal ceroid lipofuscinoses (NCLs) is through the progressive, permanent loss of motor and psychological ability with a severe intracellular accumulation of lipofuscins,<sup id="cite_ref-no23_1-0" class="reference"><a href="#cite_note-no23-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-no12_2-0" class="reference"><a href="#cite_note-no12-2"><span>[</span>2<span>]</span></a></sup> with the United States and northern European populations having slightly higher frequency with an occurrence of 1 in 10,000.<sup id="cite_ref-no15_3-0" class="reference"><a href="#cite_note-no15-3"><span>[</span>3<span>]</span></a></sup> There are four classic diagnoses that have received the most attention from researchers and the medical field, differentiated from one another by age of symptomatic onset, duration, early-onset manifestations such as blindness or seizures, and the forms which lipofuscin accumulation takes.<sup id="cite_ref-no23_1-1" class="reference"><a href="#cite_note-no23-1"><span>[</span>1<span>]</span></a></sup></p>
<p>In the early infantile variant of NCL (also called INCL or Santavuori-Haltia), <a href="/wiki/Proband" title="Proband">probands</a> appear normal at birth, but early visual loss leading to complete retinal blindness by the age of 2 years is the first indicator of the disease; by 3 years of age a vegetative state is reached and by 4 years isoelectric encephalograms confirm brain death. Late infantile variant usually manifests between 2 and 4 years of age with seizures and deterioration of vision. The maximum age before death for late infantile variant is 10–12 years.<sup id="cite_ref-no3_4-0" class="reference"><a href="#cite_note-no3-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-no4_5-0" class="reference"><a href="#cite_note-no4-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-no5_6-0" class="reference"><a href="#cite_note-no5-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-no6_7-0" class="reference"><a href="#cite_note-no6-7"><span>[</span>7<span>]</span></a></sup> Juvenile NCL (JNCL, Batten Disease, or Spielmeyer-Vogt), with a prevalence of 1 in 100,000, usually arises between 4 and 10 years of age; the first symptoms include considerable vision loss due to retinal dystrophy, with seizures, psychological degeneration, and eventual death in the mid- to late-20s or 30s ensuing.<sup id="cite_ref-no14_8-0" class="reference"><a href="#cite_note-no14-8"><span>[</span>8<span>]</span></a></sup> Adult variant NCL (ANCL or Kuf’s Disease) is less understood and generally manifests milder symptoms; however, while symptoms typically appear around 30 years of age, death usually occurs ten years later.<sup id="cite_ref-no17_9-0" class="reference"><a href="#cite_note-no17-9"><span>[</span>9<span>]</span></a></sup></p>
<p>All the mutations that have been associated with this disease have been linked to genes involved with the neural synapses metabolism – most commonly with the reuse of vesicle proteins.</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=2" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="19th_century">19th century</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=3" title="Edit section: 19th century">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The first probable instances of this condition were reported in 1826 in a Norwegian medical journal by Dr. Christian Stengel,<sup id="cite_ref-pmid16908122_10-0" class="reference"><a href="#cite_note-pmid16908122-10"><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-pmid15088608_13-0" class="reference"><a href="#cite_note-pmid15088608-13"><span>[</span>13<span>]</span></a></sup> who described 4 affected siblings in a small mining community in Norway. Although no pathological studies were performed on these children the clinical descriptions are so succinct that the diagnosis of the <a href="/w/index.php?title=Spielmeyer-Sjogren&amp;action=edit&amp;redlink=1" class="new" title="Spielmeyer-Sjogren (page does not exist)">Spielmeyer-Sjogren</a> (juvenile) type is fully justified.</p>
<h3><span class="mw-headline" id="1900_to_1950">1900 to 1950</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=4" title="Edit section: 1900 to 1950">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>More fundamental observations were reported by <a href="/wiki/Frederick_Batten" title="Frederick Batten">F. E. Batten</a> in 1903,<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> and by <a href="/wiki/Heinrich_Vogt" title="Heinrich Vogt">Heinrich Vogt</a> in 1905,<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> who performed extensive clinicopathological studies on several families. Retrospectively, these papers disclose that the authors grouped together different types of the syndrome. Furthermore Batten, at least for some time, insisted that the condition that he described was distinctly different from <a href="/wiki/Tay-Sachs_disease" title="Tay-Sachs disease" class="mw-redirect">Tay-Sachs disease</a>, the prototype of a neuronal <a href="/wiki/Lysosomal_disorder" title="Lysosomal disorder" class="mw-redirect">lysosomal disorder</a> now identified as <a href="/wiki/GM2_gangliosidosis" title="GM2 gangliosidosis" class="mw-redirect">GM2 gangliosidosis</a> type A. Around the same time, <a href="/wiki/Walther_Spielmeyer" title="Walther Spielmeyer">Walther Spielmeyer</a> reported detailed studies on three siblings,<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> suffering from the Spielmeyer-Sjogren (juvenile) type, which led him to the very firm statement that this malady is not related to <a href="/wiki/Tay-Sachs_disease" title="Tay-Sachs disease" class="mw-redirect">Tay-Sachs disease</a>. Subsequently, however, the pathomorphological studies of <a href="/wiki/K%C3%A1roly_Schaffer" title="Károly Schaffer">Károly Schaffer</a> made these authors change their minds to the extent that they reclassified their respective observations as variants of Tay-Sachs disease, which caused confusion lasting about 50 years.</p>
<p>In 1913–14, <a href="/wiki/Max_Bielschowsky" title="Max Bielschowsky">Max Bielschowsky</a> delineated the late infantile form of NCL.<sup id="cite_ref-pmid8864279_17-0" class="reference"><a href="#cite_note-pmid8864279-17"><span>[</span>17<span>]</span></a></sup> However, all forms were still thought to belong in the group of "familial amaurotic idiocies", of which Tay-Sachs was the prototype.</p>
<p>In 1931, <a href="/wiki/Torsten_Sj%C3%B6gren" title="Torsten Sjögren">Torsten Sjögren</a>, the Swedish psychiatrist and geneticist, presented 115 cases with extensive clinical and genetic documentation and came to the conclusion that the disease which we now call the Spielmeyer-Sjogren (juvenile) type is genetically separate from Tay-Sachs.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="1950_to_today">1950 to today</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=5" title="Edit section: 1950 to today">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Departing from the careful morphological observations of Spielmeyer, Hurst, and Sjovall and Ericsson, Zeman and Alpert made a determined effort to document the previously suggested pigmentary nature of the neuronal deposits in certain types of storage disorders.<sup id="cite_ref-pmid14171739_19-0" class="reference"><a href="#cite_note-pmid14171739-19"><span>[</span>19<span>]</span></a></sup> Simultaneously, Terry and Korey<sup id="cite_ref-pmid13776040_20-0" class="reference"><a href="#cite_note-pmid13776040-20"><span>[</span>20<span>]</span></a></sup> and Svennerholm<sup id="cite_ref-pmid13979552_21-0" class="reference"><a href="#cite_note-pmid13979552-21"><span>[</span>21<span>]</span></a></sup> demonstrated a specific ultrastructure and biochemistry for Tay-Sachs disease, and these developments led to the distinct identification and also separation of the NCLs from Tay-Sachs disease by Zeman and Donahue. At that time, it was proposed that the Late Infantile (Jansky-Bielschowsky), the juvenile (Spielmeyer-Vogt), and the adult form (Kufs) were quite different from Tay-Sachs disease with respect to chemical pathology and ultrastructure and also different from other forms of <a href="/wiki/Sphingolipidoses" title="Sphingolipidoses">sphingolipidoses</a>.</p>
<p>Subsequently, it was shown by Santavuori and Haltia that an infantile form of NCL exists,<sup id="cite_ref-pmid4698309_22-0" class="reference"><a href="#cite_note-pmid4698309-22"><span>[</span>22<span>]</span></a></sup> which Zeman and Dyken had included with the Jansky Bielschowsky type.</p>
<h2><span class="mw-headline" id="Forms">Forms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=6" title="Edit section: Forms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The older classification of NCL divided the condition into four types (CLN1, CLN2, CLN3, and CLN4) based upon age of onset, while newer classifications divide it by the associated gene.<sup id="cite_ref-pmid15965709_23-0" class="reference"><a href="#cite_note-pmid15965709-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup></p>
<p>CLN4 (unlike CLN1, CLN2, and CLN3) has not been mapped to a specific gene.</p>
<table class="wikitable">
<tr>
<td><b>Type</b></td>
<td><b>Description</b></td>
<td><b><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></b></td>
<td><b>Gene</b></td>
</tr>
<tr>
<td>Type 1</td>
<td><b>Infantile NCL</b> (<a href="/wiki/Santavuori-Haltia_disease" title="Santavuori-Haltia disease" class="mw-redirect">Santavuori-Haltia disease</a>, INCL): begins between about 6 months and 2 years of age and progresses rapidly. Affected children fail to thrive and have abnormally small heads (<a href="/wiki/Microcephaly" title="Microcephaly">microcephaly</a>). Also typical are short, sharp muscle contractions called myoclonic jerks. Initial signs of this disorder include delayed psychomotor development with progressive deterioration, other motor disorders, or seizures. The infantile form has the most rapid progression and children live into their mid childhood years. The gene responsible for Infantile NCL has been identified in some cases of juvenile/adult onset. It is thought these patients have some partial enzyme production that leads to a protracted, less severe disease course.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/256730">256730</a></td>
<td><a href="/wiki/PPT1" title="PPT1">PPT1</a></td>
</tr>
<tr>
<td>Type 2</td>
<td><b>Late Infantile NCL</b> (<a href="/wiki/Jansky-Bielschowsky_disease" title="Jansky-Bielschowsky disease" class="mw-redirect">Jansky-Bielschowsky disease</a>, LINCL) begins between ages 2 and 4. The typical early signs are loss of muscle coordination (<a href="/wiki/Ataxia" title="Ataxia">ataxia</a>) and seizures along with progressive mental deterioration, though afflicted children may show mild-severe delays in speech development well before other symptoms appear. This form progresses rapidly and ends in death between ages 8 and 12.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/204500">204500</a></td>
<td><a href="/wiki/TPP1" title="TPP1" class="mw-redirect">TPP1</a></td>
</tr>
<tr>
<td>Type 3</td>
<td><b>Juvenile NCL</b> (<a href="/wiki/Batten_disease" title="Batten disease">Batten disease</a>, JNCL) begins between the ages of 5 and 8 years of age. The typical early signs are progressive vision loss, seizures, ataxia or clumsiness. This form progresses less rapidly and ends in death in the late teens or early 20s, although some have been known to live into their 30s.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/204200">204200</a></td>
<td><a href="/wiki/CLN3" title="CLN3">CLN3</a></td>
</tr>
<tr>
<td>Type 4</td>
<td><b>Adult NCL</b> (<a href="/wiki/Kufs_disease" title="Kufs disease">Kufs disease</a>, ANCL) generally begins before the age of 40, causes milder symptoms that progress slowly and does not cause blindness. Although age of death is variable among affected individuals, this form does shorten life expectancy.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/204300">204300</a> (AR), <a rel="nofollow" class="external text" href="//omim.org/entry/162350">162350</a> (AD)</td>
<td><a href="/wiki/CLN6" title="CLN6">CLN6</a><sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> <a href="/wiki/DNAJC5" title="DNAJC5">DNAJC5</a></td>
</tr>
<tr>
<td>Type 5</td>
<td>Finnish Late Infantile (Finnish Late Infantile Variant, vLINCL) – identified in Finland.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/256731">256731</a></td>
<td><a href="/wiki/CLN5" title="CLN5">CLN5</a></td>
</tr>
<tr>
<td>Type 6</td>
<td>Variant Late Infantile (Late Infantile Variant, vLINCL) – identified in Costa Rica, South America, Portugal, the United Kingdom and other nations.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/601780">601780</a></td>
<td><a href="/wiki/CLN6" title="CLN6">CLN6</a></td>
</tr>
<tr>
<td>Type 7</td>
<td>CLN7</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/610951">610951</a></td>
<td><a href="/wiki/MFSD8" title="MFSD8">MFSD8</a></td>
</tr>
<tr>
<td>Type 8</td>
<td>CLN8 Northern Epilepsy, progressive epilepsy with mental retardation (EPMR)</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/610003">610003</a></td>
<td><a href="/wiki/CLN8" title="CLN8">CLN8</a></td>
</tr>
<tr>
<td>Type 8</td>
<td>Turkish Late Infantile (Turkish Late Infantile Variant,vLINCL) – identified in Turkey.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/600143">600143</a></td>
<td><a href="/wiki/CLN8" title="CLN8">CLN8</a></td>
</tr>
<tr>
<td>Type 9</td>
<td>Identified in Germany and Serbia.</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/609055">609055</a></td>
<td>Unknown, but possibly regulator of dihydro-<a href="/wiki/Ceramide_synthase" title="Ceramide synthase">ceramide synthase</a><sup id="cite_ref-pmid16303764_26-0" class="reference"><a href="#cite_note-pmid16303764-26"><span>[</span>26<span>]</span></a></sup></td>
</tr>
<tr>
<td>Type 10</td>
<td>CLN10 (Congenital, Cathepsin D Deficiency)</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/116840">116840</a></td>
<td><a href="/wiki/CTSD" title="CTSD" class="mw-redirect">CTSD</a></td>
</tr>
</table>
<h3><span class="mw-headline" id="Mutations">Mutations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=7" title="Edit section: Mutations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Infantile_form">Infantile form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=8" title="Edit section: Infantile form">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Nonsense_mutation" title="Nonsense mutation">Nonsense</a> and <a href="/wiki/Frameshift_mutation" title="Frameshift mutation">frameshift</a> mutations in the CLN1 gene (located at 1p32<sup id="cite_ref-no9_27-0" class="reference"><a href="#cite_note-no9-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-no13_28-0" class="reference"><a href="#cite_note-no13-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-no29_29-0" class="reference"><a href="#cite_note-no29-29"><span>[</span>29<span>]</span></a></sup>) always induce classical INCL, while some <a href="/wiki/Missense_mutation" title="Missense mutation">misssense mutations</a> have been associated with ANCL in addition to the Infantile and Juvenile forms. The mutation typically results in a deficient form of a <a href="/wiki/Lysosome" title="Lysosome">lysosomal</a> <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> called <a href="/wiki/Palmitoyl_protein_thioesterase" title="Palmitoyl protein thioesterase">palmitoyl protein thioesterase</a> 1 (PPT1).<sup id="cite_ref-no1_30-0" class="reference"><a href="#cite_note-no1-30"><span>[</span>30<span>]</span></a></sup></p>
<p>The <a href="/wiki/Wild_type" title="Wild type">wild type</a> PPT1 is a 306 <a href="/wiki/Amino_acid" title="Amino acid">amino acid</a> <a href="/wiki/Polypeptide" title="Polypeptide" class="mw-redirect">polypeptide</a> that is typically targeted for transport into <a href="/wiki/Lysosome" title="Lysosome">lysosomes</a> by the <a href="/wiki/Mannose_6-phosphate" title="Mannose 6-phosphate">mannose 6-phosphate</a> (M6P) receptor mediated pathway.<sup id="cite_ref-no3_4-1" class="reference"><a href="#cite_note-no3-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-no1_30-1" class="reference"><a href="#cite_note-no1-30"><span>[</span>30<span>]</span></a></sup> Here the protein appears to function in removing <a href="/wiki/Palmitate" title="Palmitate" class="mw-redirect">palmitate</a> <a href="/wiki/Residue_(chemistry)" title="Residue (chemistry)">residues</a> by cleaving <a href="/wiki/Thioester" title="Thioester">thioester</a> linkages in s-acylated (or palmitoylated) proteins, encouraging their breakdown.<sup id="cite_ref-no3_4-2" class="reference"><a href="#cite_note-no3-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-no4_5-1" class="reference"><a href="#cite_note-no4-5"><span>[</span>5<span>]</span></a></sup> Defective <a href="/wiki/Polypeptides" title="Polypeptides" class="mw-redirect">polypeptides</a>, however, are unable to exit the <a href="/wiki/Endoplasmic_reticulum" title="Endoplasmic reticulum">endoplasmic reticulum</a> (ER), most likely due to <a href="/w/index.php?title=Protien_folding&amp;action=edit&amp;redlink=1" class="new" title="Protien folding (page does not exist)">misfolding</a>; further analyses of this pathway could serve to categorize INCL among lysosomal enzyme deficiencies. It is important to note that the human PPT gene shows 91% similarity to bovine PPT and 85% similarity to rat PPT; these data indicate that the PPT gene is highly conserved and likely plays a vital role in cell metabolism.<sup id="cite_ref-no3_4-3" class="reference"><a href="#cite_note-no3-4"><span>[</span>4<span>]</span></a></sup> In addition buildup of defective PPT1 in the ER has been shown to cause the increased release of Ca2+. This <a href="/wiki/Homeostasis" title="Homeostasis">homeostasis</a>-altering event leads to increased <a href="/wiki/Mitochondrial" title="Mitochondrial" class="mw-redirect">mitochondrial</a> membrane permeability and subsequent activation of <a href="/wiki/Caspase-9" title="Caspase-9">caspase-9</a>, eventually leading to an accumulation of cleaved and uncleaved poly(ADP-ribose) polymerase (PARP) and eventual <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a>.<sup id="cite_ref-no4_5-2" class="reference"><a href="#cite_note-no4-5"><span>[</span>5<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Late_infantile_form">Late infantile form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=9" title="Edit section: Late infantile form">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The CLN2 gene encodes a 46kDa protein called lysosomal <a href="/wiki/Tripeptidyl_peptidase_I" title="Tripeptidyl peptidase I">tripeptidyl peptidase I</a> (TPPI) which cleaves tripeptides from terminal <a href="/wiki/Amine" title="Amine">amine</a> groups of partially unfolded proteins.<sup id="cite_ref-no5_6-1" class="reference"><a href="#cite_note-no5-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-no20_31-0" class="reference"><a href="#cite_note-no20-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-no20_31-1" class="reference"><a href="#cite_note-no20-31"><span>[</span>31<span>]</span></a></sup> Mutations of this gene typically result in a LINCL phenotype.<sup id="cite_ref-no8_32-0" class="reference"><a href="#cite_note-no8-32"><span>[</span>32<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Juvenile_form">Juvenile form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=10" title="Edit section: Juvenile form">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>All mutations resulting in the Juvenile variant of NCL have been shown to occur at the CLN3 gene on 16p12;<sup id="cite_ref-no13_28-1" class="reference"><a href="#cite_note-no13-28"><span>[</span>28<span>]</span></a></sup> of the mutations known to cause JNCL, 85% result from a 1.02 kb deletion, with a loss of amino acids 154–438, while the remaining 15% appear to result from either point or <a href="/wiki/Frameshift_mutation" title="Frameshift mutation">frameshift mutations</a>.<sup id="cite_ref-no14_8-1" class="reference"><a href="#cite_note-no14-8"><span>[</span>8<span>]</span></a></sup> The wild type CLN3 gene codes for a protein with no known function;<sup id="cite_ref-no12_2-1" class="reference"><a href="#cite_note-no12-2"><span>[</span>2<span>]</span></a></sup> however, studies of the yeast CLN3 <a href="/wiki/Ortholog" title="Ortholog" class="mw-redirect">ortholog</a>, the product of which is called <a href="/wiki/Battenin" title="Battenin" class="mw-redirect">Battenin</a> (after its apparent connections to Batten’s Disease, or JNCL), have suggested that the protein may play a role in lysosomal <a href="/wiki/PH" title="PH">pH</a> <a href="/wiki/Homeostasis" title="Homeostasis">homeostasis</a>. Furthermore, recent studies have also implied the protein’s role in <a href="/wiki/Cathepsin_D" title="Cathepsin D">cathepsin D</a> deficiency; the overexpression of the defective protein appears to have significant effects on <a href="/wiki/Cathepsin_D" title="Cathepsin D">cathepsin D</a> processing, with implications suggesting that accumulation of ATP synthase subunit C would result.<sup id="cite_ref-no16_33-0" class="reference"><a href="#cite_note-no16-33"><span>[</span>33<span>]</span></a></sup> Only recently have studies of human patients shown deficiency of lysosomal aspartyl proteinase cathepsin D.</p>
<h4><span class="mw-headline" id="Adult_dominant_form">Adult dominant form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=11" title="Edit section: Adult dominant form">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Between 1.3% and 10% of cases are of the adult form. The age at onset is variable (6–62 yr). Two main clinical subtypes have been described: progressive myoclonus epilepsy (type A) and dementia with motor disturbances, such as cerebellar, extrapyramidal signs and dyskinesia (type B). Unlike the other NCLs retinal degeneration is absent. Pathologically the ceroid-lipofuscin accumulates mainly in neurons and contains subunit C of the mitochondrial <a href="/wiki/ATP_synthase" title="ATP synthase">ATP synthase</a>.</p>
<p>Two independent families have been shown to have mutations in the <a href="/wiki/DNAJC5" title="DNAJC5">DNAJC5</a> gene – one with a <a href="/w/index.php?title=Transvertion&amp;action=edit&amp;redlink=1" class="new" title="Transvertion (page does not exist)">transvertion</a> and the other with a deletion mutation.<sup id="cite_ref-Benitez2011_34-0" class="reference"><a href="#cite_note-Benitez2011-34"><span>[</span>34<span>]</span></a></sup> The muations occur in a <a href="/wiki/Cysteine" title="Cysteine">cysteine</a>-string domain, which is required for membrane targeting/binding, palmitoylation and oligomerization of the encoded protein cysteine-string protein alpha (CSPα). The mutations dramatically decrease the affinity of CSPα for the membrane. A second report has also located this disease to this gene.<sup id="cite_ref-Noskova2011_35-0" class="reference"><a href="#cite_note-Noskova2011-35"><span>[</span>35<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Incidence">Incidence</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=12" title="Edit section: Incidence">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Incidence can vary greatly from type-to-type, and from country-to-country.<sup id="cite_ref-urleMedicine_-_Neuronal_Ceroid_Lipofuscinoses_:_Article_by_Celia_H_Chang_36-0" class="reference"><a href="#cite_note-urleMedicine_-_Neuronal_Ceroid_Lipofuscinoses_:_Article_by_Celia_H_Chang-36"><span>[</span>36<span>]</span></a></sup></p>
<p>In Germany, one study reported an incidence of 1.28 per 100,000.<sup id="cite_ref-pmid1609834_37-0" class="reference"><a href="#cite_note-pmid1609834-37"><span>[</span>37<span>]</span></a></sup></p>
<p>A study in Italy reported an incidence of 0.56 per 100,000.<sup id="cite_ref-pmid7668318_38-0" class="reference"><a href="#cite_note-pmid7668318-38"><span>[</span>38<span>]</span></a></sup></p>
<p>A study in Norway reported an incidence of 3.9 per 100,000 using the years from 1978 to 1999, with a lower rate in earlier decades.<sup id="cite_ref-pmid17092455_39-0" class="reference"><a href="#cite_note-pmid17092455-39"><span>[</span>39<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Inheritance">Inheritance</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=13" title="Edit section: Inheritance">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Childhood NCLs are disordially <a href="/wiki/Recessive_gene" title="Recessive gene" class="mw-redirect">autosomal recessive</a> disorders; that is, they occur only when a child inherits two copies of the defective gene, one from each parent. When both parents carry one defective <a href="/wiki/Gene" title="Gene">gene</a>, each of their children faces one in four chance of developing NCL. At the same time, each child also faces a one in two chance of inheriting just one copy of the defective gene. Individuals who have only one defective gene are known as carriers, meaning they do not develop the disease, but they can pass the gene on to their own children.</p>
<p>Adult NCL may be inherited as an <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> (Kufs) or, less often, as an <a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">autosomal dominant</a> (Parry's) disorder. In <a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">autosomal dominant</a> <a href="/wiki/Inheritance" title="Inheritance">inheritance</a>, all people who inherit a single copy of the disease gene develop the disease. As a result, there are no unaffected carriers of the <a href="/wiki/Gene" title="Gene">gene</a>.</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=14" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Because vision loss is often an early sign, Batten disease/NCL may be first suspected during an eye exam. An eye doctor can detect a loss of cells within the eye that occurs in the three childhood forms of Batten disease/NCL. However, because such cell loss occurs in other eye diseases, the disorder cannot be diagnosed by this sign alone. Often an eye specialist or other physician who suspects Batten disease/NCL may refer the child to a neurologist, a doctor who specializes in disease of the brain and nervous system. In order to diagnose Batten disease/NCL, the neurologist needs the patient's medical history and information from various laboratory tests.</p>
<p>Diagnostic tests used for Batten disease/NCLs include:</p>
<ul>
<li>Skin or tissue sampling. The doctor can examine a small piece of tissue under an <a href="/wiki/Electron_microscope" title="Electron microscope">electron microscope</a>. The powerful magnification of the microscope helps the doctor spot typical NCL deposits. These deposits are found in many different tissues, including <a href="/wiki/Skin" title="Skin">skin</a>, <a href="/wiki/Muscle" title="Muscle">muscle</a>, <a href="/wiki/Conjunctiva" title="Conjunctiva">conjunctiva</a>, <a href="/wiki/Rectal" title="Rectal" class="mw-redirect">rectal</a> and others. Blood can also be used.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="A clinician is unlikely to make use of an electron microscope; the inclusions are often easily seen using light microscopy (November 2008)">citation needed</span></a></i>]</sup> These deposits take on characteristic shapes, depending on the variant under which they are said to occur: granular osmophilic deposits (GRODs) are generally characteristic of INCL, while <a href="/wiki/Curvilinear" title="Curvilinear" class="mw-redirect">curvilinear</a> profiles, fingerprint profiles, and mixed-type inclusions are typically found in LINCL, JNCL, and ANCL, respectively.</li>
<li><a href="/wiki/Electroencephalogram" title="Electroencephalogram" class="mw-redirect">Electroencephalogram</a> or EEG. An EEG uses special patches placed on the scalp to record electrical currents inside the brain. This helps doctors see telltale patterns in the brain's electrical activity that suggest a patient has <a href="/wiki/Seizures" title="Seizures" class="mw-redirect">seizures</a>.</li>
<li>Electrical studies of the eyes. These tests, which include <a href="/wiki/Visual-evoked_response" title="Visual-evoked response" class="mw-redirect">visual-evoked responses</a> (VER) and <a href="/wiki/Electroretinography" title="Electroretinography">electroretinograms</a> (ERG), can detect various eye problems common in childhood Batten disease/NCLs.</li>
<li>Brain scans. Imaging can help doctors look for changes in the brain's appearance. The most commonly used imaging technique is <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">computed tomography</a> (CT), which uses x-rays and a computer to create a sophisticated picture of the brain's tissues and structures. A CT scan may reveal brain areas that are decaying in NCL patients. A second imaging technique that is increasingly common is <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a>, or MRI. MRI uses a combination of magnetic fields and radio waves, instead of radiation, to create a picture of the brain.</li>
<li>Enzyme assay. A recent development in diagnosis of Batten disease/NCL is the use of enzyme assays that look for specific missing <a href="/wiki/Lysosome" title="Lysosome">lysosomal</a> <a href="/wiki/Enzyme" title="Enzyme">enzymes</a> for infantile and late infantile only. This is a quick and easy diagnostic test.</li>
</ul>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=15" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Currently there is no widely accepted treatment that can cure, slow down, or halt the symptoms of NCL. However, seizures may be controlled or reduced with use of anti-epileptic drugs. Additionally, physical, speech, and occupational therapies may help affected patients retain functioning for as long as possible.</p>
<p>Several experimental treatments are under investigation.</p>
<h3><span class="mw-headline" id="Cystagon">Cystagon</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=16" title="Edit section: Cystagon">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2001 it was reported a drug used to treat <a href="/wiki/Cystinosis" title="Cystinosis">cystinosis</a>, a rare genetic disease that can cause kidney failure if not treated, may be useful in treating the infantile form of NCL. Preliminary results report the drug has completely cleared away storage material from the white blood cells of the first six patients, as well as slowing down the rapid neurodegeneration of infantile NCL.</p>
<p>It is preliminarily shown that the addition of another drug seems to be more effective than <a href="/wiki/Cystagon" title="Cystagon" class="mw-redirect">Cystagon</a> alone and all patients on the trials, including the first six, are being put on this drug.</p>
<p>Currently there are two drug trials underway for infantile Batten disease/NCL. Both trials are using the drug Cystagon. For additional information regarding this trial, contact the <a rel="nofollow" class="external text" href="http://bdsra.org">Batten Disease Support and Research Association</a>.</p>
<h3><span class="mw-headline" id="Gene_therapy">Gene therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=17" title="Edit section: Gene therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A <a href="/wiki/Gene_therapy" title="Gene therapy">gene therapy</a> trial using an adeno-associated virus vector called AAV2CUhCLN2 began in June 2004 in an attempt to treat the manifestations of Late Infantile NCL.<sup id="cite_ref-safety_study_40-0" class="reference"><a href="#cite_note-safety_study-40"><span>[</span>40<span>]</span></a></sup> The trial was conducted by Weill Medical College of Cornell University<sup id="cite_ref-safety_study_40-1" class="reference"><a href="#cite_note-safety_study-40"><span>[</span>40<span>]</span></a></sup> and sponsored by the Nathan's Battle Foundation.<sup id="cite_ref-urlNathans_Battle_.7C_Clinical_Trial_Efforts_41-0" class="reference"><a href="#cite_note-urlNathans_Battle_.7C_Clinical_Trial_Efforts-41"><span>[</span>41<span>]</span></a></sup> In May 2008, it was reported that the gene therapy given to the recipients was "safe; and that, on average, it significantly slowed the disease's progression during the 18-month follow-up period"<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup> and "suggested that higher doses and a better delivery system may provide greater benefit".<sup id="cite_ref-safety_study_Rh.10_43-0" class="reference"><a href="#cite_note-safety_study_Rh.10-43"><span>[</span>43<span>]</span></a></sup></p>
<p>A second gene therapy trial for Late Infantile NCL using an adeno-associated virus derived from <a href="/wiki/Rhesus_macaque" title="Rhesus macaque">rhesus macaque</a> (a species of <a href="/wiki/Old_World_monkey" title="Old World monkey">Old World monkey</a>) called AAVrh.10 began in August 2010 and is once again being conducted by Weill Medical College of Cornell University.<sup id="cite_ref-safety_study_Rh.10_43-1" class="reference"><a href="#cite_note-safety_study_Rh.10-43"><span>[</span>43<span>]</span></a></sup> Animal models of Late Infantile NCL showed that the AAVrh.10 delivery system "was much more effective, giving better spread of the gene product and improving survival greatly".<sup id="cite_ref-safety_study_Rh.10_43-2" class="reference"><a href="#cite_note-safety_study_Rh.10-43"><span>[</span>43<span>]</span></a></sup></p>
<p>A third gene therapy trial, using the same AAVrh.10 delivery system, began in 2011 and been expanded to include Late Infantile NCL patients with moderate/severe impairment or uncommon genotypes and uses a novel administration method that reduces general anesthesia time by 50% in order to minimize potential adverse side effects.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Flupirtine">Flupirtine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=18" title="Edit section: Flupirtine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A painkiller available in several European countries, <a href="/wiki/Flupirtine" title="Flupirtine">Flupirtine</a>, has been suggested to possibly slow down the progress of NCL,<sup id="cite_ref-pmid11921051_45-0" class="reference"><a href="#cite_note-pmid11921051-45"><span>[</span>45<span>]</span></a></sup> particularly in the juvenile and late infantile forms. No trial has been officially supported in this venue, however. Currently the drug is available to NCL families either from Germany, Duke University Medical Center in <a href="/wiki/Durham,_North_Carolina" title="Durham, North Carolina">Durham, North Carolina</a>, and the Hospital for Sick Children in <a href="/wiki/Toronto" title="Toronto">Toronto, Ontario</a>.</p>
<h3><span class="mw-headline" id="Stem_cells">Stem cells</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=19" title="Edit section: Stem cells">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>On October 20, 2005, the Food and Drug Administration approved a phase I clinical trial of neural stem cells to treat infantile and late infantile Batten disease. Subsequent approval from an independent review board also approved the stem cell therapy in early March 2006. This treatment will be the first ever transplant of fetal stem cells performed on humans. The therapy is being developed by Stem Cells Inc and is estimated to have six patients. The treatment will be carried out in Oregon.<sup id="cite_ref-urlStudy_of_the_Safety_and_Preliminary_Effectiveness_of_Human_Central_Nervous_System_.28CNS.29_Stem_Cells_.28HuCNS-SC.29_in_Patients_With_Infantile_or_Late_Infantile_Neuronal_Ceroid_Lipofuscinosis_.28NCL.29_-_Full_Text_View_-_ClinicalTrials.gov_46-0" class="reference"><a href="#cite_note-urlStudy_of_the_Safety_and_Preliminary_Effectiveness_of_Human_Central_Nervous_System_.28CNS.29_Stem_Cells_.28HuCNS-SC.29_in_Patients_With_Infantile_or_Late_Infantile_Neuronal_Ceroid_Lipofuscinosis_.28NCL.29_-_Full_Text_View_-_ClinicalTrials.gov-46"><span>[</span>46<span>]</span></a></sup></p>
<p>Juvenile NCL has recently been listed on the Federal Clinical Trials website to test the effectiveness of bone marrow/stem cell transplants for this condition. A bone marrow transplant has been attempted in the late infantile form of NCL with disappointing results; while the transplant may have slowed the onset of the disease, the child eventually developed the disease and died in 1998.</p>
<p>Trials testing the effectiveness of bone marrow transplants for infantile NCL in Finland have also been disappointing, with only a slight slowing of disease reported.<sup id="cite_ref-pmid11673581_47-0" class="reference"><a href="#cite_note-pmid11673581-47"><span>[</span>47<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Immunosuppressants">Immunosuppressants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=20" title="Edit section: Immunosuppressants">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In late 2007, it was reported by Dr. David Pearce et al. that <a href="/wiki/Cellcept" title="Cellcept" class="mw-redirect">Cellcept</a>, an <a href="/wiki/Immunosuppressant" title="Immunosuppressant" class="mw-redirect">immunosuppressant</a> medication commonly used in <a href="/wiki/Bone_marrow_transplant" title="Bone marrow transplant" class="mw-redirect">bone marrow transplants</a>, may be useful in slowing down the progress of Juvenile NCL.<sup id="cite_ref-urlBDSRA_-_Batten_Disease_Support_and_Research_Association_48-0" class="reference"><a href="#cite_note-urlBDSRA_-_Batten_Disease_Support_and_Research_Association-48"><span>[</span>48<span>]</span></a></sup> Fundraising is currently underway to gather the funds needed to start a clinical trial to test the safety and efficiency of CellCept for Juvenile NCL.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=21" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-no23-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-no23_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no23_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Pardo, C. et al. (1994). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1887237">"Accumulation of the adenosine triphosphate synthase subunit c in the mnd mutant mouse"</a>. <i>Am J Path</i> <b>144</b> (4): 829–835. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1887237">1887237</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8160780">8160780</a>. <q>There are more than eight variants of NCL, found in 1 in 12,500 people worldwide.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Accumulation+of+the+adenosine+triphosphate+synthase+subunit+c+in+the+mnd+mutant+mouse&amp;rft.aulast=Pardo%2C+C.&amp;rft.au=Pardo%2C+C.&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1887237&amp;rft_id=info%3Apmc%2F1887237&amp;rft_id=info%3Apmid%2F8160780&amp;rft.issue=4&amp;rft.jtitle=Am+J+Path&amp;rft.pages=829-835&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=144" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no12-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-no12_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no12_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Narayan SB, Pastor JV, Mitchison HM, Bennett MJ (Aug 2004). "CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease". <i>Brain</i> <b>127</b> (Pt 8): 1748–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fbrain%2Fawh195">10.1093/brain/awh195</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15240430">15240430</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=CLN3L%2C+a+novel+protein+related+to+the+Batten+disease+protein%2C+is+overexpressed+in+Cln3-%2F-+mice+and+in+Batten+disease&amp;rft.aulast=Narayan+SB%2C+Pastor+JV%2C+Mitchison+HM%2C+Bennett+MJ&amp;rft.au=Narayan+SB%2C+Pastor+JV%2C+Mitchison+HM%2C+Bennett+MJ&amp;rft.date=Aug+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawh195&amp;rft_id=info%3Apmid%2F15240430&amp;rft.issue=Pt+8&amp;rft.jtitle=Brain&amp;rft.pages=1748-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=127" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-no15-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-no15_3-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vesa J, Chin MH, Oelgeschläger K et al. (Jul 2002). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC117323">"Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3"</a>. <i>Mol Biol Cell</i> <b>13</b> (7): 2410–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1091%2Fmbc.E02-01-0031">10.1091/mbc.E02-01-0031</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC117323">117323</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12134079">12134079</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Neuronal+ceroid+lipofuscinoses+are+connected+at+molecular+level%3A+interaction+of+CLN5+protein+with+CLN2+and+CLN3&amp;rft.aulast=Vesa+J%2C+Chin+MH%2C+Oelgeschl%C3%A4ger+K&amp;rft.au=Vesa+J%2C+Chin+MH%2C+Oelgeschl%C3%A4ger+K&amp;rft.date=Jul+2002&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC117323&amp;rft_id=info%3Adoi%2F10.1091%2Fmbc.E02-01-0031&amp;rft_id=info%3Apmc%2F117323&amp;rft_id=info%3Apmid%2F12134079&amp;rft.issue=7&amp;rft.jtitle=Mol+Biol+Cell&amp;rft.pages=2410-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no3-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-no3_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no3_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-no3_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-no3_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hellstein, E. et al. (1996). "Human palmitoyl protein thioesterase". <i>Eur Mol Bio Org J</i> <b>15</b> (19): 5240–5.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Human+palmitoyl+protein+thioesterase&amp;rft.au=Hellstein%2C+E.&amp;rft.aulast=Hellstein%2C+E.&amp;rft.date=1996&amp;rft.genre=article&amp;rft.issue=19&amp;rft.jtitle=Eur+Mol+Bio+Org+J&amp;rft.pages=5240-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no4-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-no4_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no4_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-no4_5-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kim, S. et al. (2006). "PPT1 deficiency leads to the activation of caspase-9 and contributes to rapid neurodegeneration in INCL". <i>Hum Mol Gen</i> <b>15</b> (10): 1586–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhmg%2Fddl078">10.1093/hmg/ddl078</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16571600">16571600</a>. <q>Late Infantile NCL (LINCL or Jansky-Bielschowsky), on the other hand, initially presents as generalized tonic-clonic or myoclonic seizures beginning at around 2–3 years of age; following this is depressed cognitive development including slow learning, speech delays, and eventual dementia leading to death, usually between 14 and 36 years of age.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=PPT1+deficiency+leads+to+the+activation+of+caspase-9+and+contributes+to+rapid+neurodegeneration+in+INCL&amp;rft.au=Kim%2C+S.&amp;rft.aulast=Kim%2C+S.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2Fddl078&amp;rft_id=info%3Apmid%2F16571600&amp;rft.issue=10&amp;rft.jtitle=Hum+Mol+Gen&amp;rft.pages=1586-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no5-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-no5_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no5_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ju, W. et al. (2002). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1735024">"Identification of CLN2 mutations shows Canadian specific NCL2 alleles"</a>. <i>Journal of Medical Genetics</i> <b>39</b> (11): 822–825. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fjmg.39.11.822">10.1136/jmg.39.11.822</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1735024">1735024</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12414822">12414822</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Identification+of+CLN2+mutations+shows+Canadian+specific+NCL2+alleles&amp;rft.au=Ju%2C+W.&amp;rft.aulast=Ju%2C+W.&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1735024&amp;rft_id=info%3Adoi%2F10.1136%2Fjmg.39.11.822&amp;rft_id=info%3Apmc%2F1735024&amp;rft_id=info%3Apmid%2F12414822&amp;rft.issue=11&amp;rft.jtitle=Journal+of+Medical+Genetics&amp;rft.pages=822-825&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no6-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-no6_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Isosomppi, J. et al. (2002). "Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein". <i>Hum Mol Gen</i> <b>11</b> (8): 885–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhmg%2F11.8.885">10.1093/hmg/11.8.885</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11971870">11971870</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Lysosomal+localization+of+the+neuronal+ceroid+lipofuscinosis+CLN5+protein&amp;rft.au=Isosomppi%2C+J.&amp;rft.aulast=Isosomppi%2C+J.&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2F11.8.885&amp;rft_id=info%3Apmid%2F11971870&amp;rft.issue=8&amp;rft.jtitle=Hum+Mol+Gen&amp;rft.pages=885-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no14-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-no14_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no14_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Persaud-Sawin, D. et al. (2002). "Motifs within the CLN3 protein". <i>Hum Mol Gen</i> <b>11</b> (18): 2129–2142. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhmg%2F11.18.2129">10.1093/hmg/11.18.2129</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12189165">12189165</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Motifs+within+the+CLN3+protein&amp;rft.aulast=Persaud-Sawin%2C+D.&amp;rft.au=Persaud-Sawin%2C+D.&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2F11.18.2129&amp;rft_id=info%3Apmid%2F12189165&amp;rft.issue=18&amp;rft.jtitle=Hum+Mol+Gen&amp;rft.pages=2129-2142&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no17-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-no17_9-0">^</a></b></span> <span class="reference-text"><span class="citation book">Wisnewsky, Krystyna E et al. (2006). "Neuronal Ceroid Lipofuscinoses". <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=gene.chapter.ncl"><i>GeneReviews (NCBI)</i></a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Neuronal+Ceroid+Lipofuscinoses&amp;rft.aufirst=Krystyna+E&amp;rft.aulast=Wisnewsky&amp;rft.au=Wisnewsky%2C+Krystyna+E&amp;rft.btitle=GeneReviews+%28NCBI%29&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2Fbv.fcgi%3Frid%3Dgene.chapter.ncl&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid16908122-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16908122_10-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Haltia M (October 2006). <a rel="nofollow" class="external text" href="http://www.helsinki.fi/neurosci/Jalanko_Haltia.pdf">"The neuronal ceroid-lipofuscinoses: from past to present"</a> <span style="font-size:85%;">(PDF)</span>. <i>Biochim. Biophys. Acta</i> <b>1762</b> (10): 850–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.bbadis.2006.06.010">10.1016/j.bbadis.2006.06.010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16908122">16908122</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=The+neuronal+ceroid-lipofuscinoses%3A+from+past+to+present&amp;rft.au=Haltia+M&amp;rft.aulast=Haltia+M&amp;rft.date=October+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.helsinki.fi%2Fneurosci%2FJalanko_Haltia.pdf&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbadis.2006.06.010&amp;rft_id=info%3Apmid%2F16908122&amp;rft.issue=10&amp;rft.jtitle=Biochim.+Biophys.+Acta&amp;rft.pages=850-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1762" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><i><a rel="nofollow" class="external text" href="http://www.whonamedit.com/synd.cfm/7.html">synd/7</a></i> at <a href="/wiki/Who_Named_It%3F" title="Who Named It?" class="mw-redirect">Who Named It?</a></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text">C. Stengel. Beretning om et mærkeligt Sygdomstilfelde hos fire Sødskende. Eyr, 1826.</span></li>
<li id="cite_note-pmid15088608-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15088608_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Brean A (April 2004). "[An account of a strange instance of disease—Stengel-Batten-Spielmayer-Vogt disease]". <i>Tidsskr. Nor. Laegeforen.</i> (in Norwegian) <b>124</b> (7): 970–1. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15088608">15088608</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=%5BAn+account+of+a+strange+instance+of+disease%E2%80%94Stengel-Batten-Spielmayer-Vogt+disease%5D&amp;rft.au=Brean+A&amp;rft.aulast=Brean+A&amp;rft.date=April+2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15088608&amp;rft.issue=7&amp;rft.jtitle=Tidsskr.+Nor.+Laegeforen.&amp;rft.pages=970-1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=124" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Batten, F. E. (1902). "Cerebral degeneration with symmetrical changes in the maculae in two members of a family". <i>Transactions of the Ophthalmological Societies of the United Kingdom</i> <b>23</b>: 386–90.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Cerebral+degeneration+with+symmetrical+changes+in+the+maculae+in+two+members+of+a+family&amp;rft.au=Batten%2C+F.+E.&amp;rft.aulast=Batten%2C+F.+E.&amp;rft.date=1902&amp;rft.genre=article&amp;rft.jtitle=Transactions+of+the+Ophthalmological+Societies+of+the+United+Kingdom&amp;rft.pages=386-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Vogt, H. (1905). "Über familiäre amaurotische Idiotie und verwandte Krankheitsbilder". <i>Monatsschrift für Psychiatrie und Neurologie</i> (Basel) <b>18</b> (2): 161–71, 310–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000213427">10.1159/000213427</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=%C3%9Cber+famili%C3%A4re+amaurotische+Idiotie+und+verwandte+Krankheitsbilder&amp;rft.aulast=Vogt%2C+H.&amp;rft.au=Vogt%2C+H.&amp;rft.date=1905&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000213427&amp;rft.issue=2&amp;rft.jtitle=Monatsschrift+f%C3%BCr+Psychiatrie+und+Neurologie&amp;rft.pages=161-71%2C+310-57&amp;rft.place=Basel&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text">W. Spielmeyer. Klinische und anatomische Untersuchungen über eine besondere Form von familiärer amaurotische Idiotie. Freiburg im Breisgau, Gotha, 1907. Reprinted in Nissl: Histologische und histopathologische Arbeiten über die Grosshirnrinde 1908, 2: 193–213.</span></li>
<li id="cite_note-pmid8864279-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8864279_17-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Goebel HH, Gerhard L, Kominami E, Haltia M (July 1996). "Neuronal ceroid-lipofuscinosis—late-infantile or Jansky-Bielschowsky type—revisited". <i>Brain Pathol.</i> <b>6</b> (3): 225–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1750-3639.1996.tb00850.x">10.1111/j.1750-3639.1996.tb00850.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8864279">8864279</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Neuronal+ceroid-lipofuscinosis%E2%80%94late-infantile+or+Jansky-Bielschowsky+type%E2%80%94revisited&amp;rft.au=Goebel+HH%2C+Gerhard+L%2C+Kominami+E%2C+Haltia+M&amp;rft.aulast=Goebel+HH%2C+Gerhard+L%2C+Kominami+E%2C+Haltia+M&amp;rft.date=July+1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1750-3639.1996.tb00850.x&amp;rft_id=info%3Apmid%2F8864279&amp;rft.issue=3&amp;rft.jtitle=Brain+Pathol.&amp;rft.pages=225-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text">K. G. T. Sjögren. Die juvenile amaurotische Idiotie. 1931.</span></li>
<li id="cite_note-pmid14171739-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14171739_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zeman W, Alpert M (1963). "On the nature of the "stored" lipid substances in juvenile amaurotic idiocy (Batten-Spielmeyer-Vogt)". <i>Ann Histochim</i> <b>8</b>: 255–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14171739">14171739</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=On+the+nature+of+the+%22stored%22+lipid+substances+in+juvenile+amaurotic+idiocy+%28Batten-Spielmeyer-Vogt%29&amp;rft.aulast=Zeman+W%2C+Alpert+M&amp;rft.au=Zeman+W%2C+Alpert+M&amp;rft.date=1963&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14171739&amp;rft.jtitle=Ann+Histochim&amp;rft.pages=255-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid13776040-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13776040_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Terry RD, Korey SR (Dec 1960). "Membranous cytoplasmic granules in infantile amaurotic idiocy". <i>Nature</i> <b>188</b> (4755): 1000–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F1881000a0">10.1038/1881000a0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13776040">13776040</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Membranous+cytoplasmic+granules+in+infantile+amaurotic+idiocy&amp;rft.aulast=Terry+RD%2C+Korey+SR&amp;rft.au=Terry+RD%2C+Korey+SR&amp;rft.date=Dec+1960&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2F1881000a0&amp;rft_id=info%3Apmid%2F13776040&amp;rft.issue=4755&amp;rft.jtitle=Nature&amp;rft.pages=1000-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=188" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid13979552-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13979552_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Svennerholm L (November 1962). "The chemical structure of normal human brain and Tay-Sachs gangliosides". <i>Biochem. Biophys. Res. Commun.</i> <b>9</b> (5): 436–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0006-291X%2862%2990030-X">10.1016/0006-291X(62)90030-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13979552">13979552</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=The+chemical+structure+of+normal+human+brain+and+Tay-Sachs+gangliosides&amp;rft.aulast=Svennerholm+L&amp;rft.au=Svennerholm+L&amp;rft.date=November+1962&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0006-291X%2862%2990030-X&amp;rft_id=info%3Apmid%2F13979552&amp;rft.issue=5&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.pages=436-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid4698309-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid4698309_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Santavuori P, Haltia M, Rapola J, Raitta C (Mar 1973). "Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients". <i>J Neurol Sci.</i> <b>18</b> (3): 257–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0022-510X%2873%2990075-0">10.1016/0022-510X(73)90075-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4698309">4698309</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Infantile+type+of+so-called+neuronal+ceroid-lipofuscinosis.+1.+A+clinical+study+of+15+patients&amp;rft.aulast=Santavuori+P%2C+Haltia+M%2C+Rapola+J%2C+Raitta+C&amp;rft.au=Santavuori+P%2C+Haltia+M%2C+Rapola+J%2C+Raitta+C&amp;rft.date=Mar+1973&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0022-510X%2873%2990075-0&amp;rft_id=info%3Apmid%2F4698309&amp;rft.issue=3&amp;rft.jtitle=J+Neurol+Sci.&amp;rft.pages=257-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15965709-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15965709_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mole SE, Williams RE, Goebel HH (September 2005). "Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses". <i>Neurogenetics</i> <b>6</b> (3): 107–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs10048-005-0218-3">10.1007/s10048-005-0218-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15965709">15965709</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Correlations+between+genotype%2C+ultrastructural+morphology+and+clinical+phenotype+in+the+neuronal+ceroid+lipofuscinoses&amp;rft.aulast=Mole+SE%2C+Williams+RE%2C+Goebel+HH&amp;rft.au=Mole+SE%2C+Williams+RE%2C+Goebel+HH&amp;rft.date=September+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs10048-005-0218-3&amp;rft_id=info%3Apmid%2F15965709&amp;rft.issue=3&amp;rft.jtitle=Neurogenetics&amp;rft.pages=107-26&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><a href="/wiki/Mendelian_Inheritance_in_Man" title="Mendelian Inheritance in Man" class="mw-redirect">Online 'Mendelian Inheritance in Man'</a> (OMIM) <a rel="nofollow" class="external text" href="//omim.org/entry/256730">256730</a></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Arsov, T et al. (13 May 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3146726">"Kufs Disease, the Major Adult Form of Neuronal Ceroid Lipofuscinosis, Caused by Mutations in CLN6"</a>. <i>American Journal of Human Genetics</i> <b>88</b> (5): 566–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ajhg.2011.04.004">10.1016/j.ajhg.2011.04.004</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3146726">3146726</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21549341">21549341</a><span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Kufs+Disease%2C+the+Major+Adult+Form+of+Neuronal+Ceroid+Lipofuscinosis%2C+Caused+by+Mutations+in+CLN6&amp;rft.au=Arsov%2C+T&amp;rft.aufirst=T&amp;rft.aulast=Arsov&amp;rft.date=13+May+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3146726&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ajhg.2011.04.004&amp;rft_id=info%3Apmc%2F3146726&amp;rft_id=info%3Apmid%2F21549341&amp;rft.issue=5&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.pages=566-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=88" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid16303764-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16303764_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schulz A, Mousallem T, Venkataramani M et al. (February 2006). <a rel="nofollow" class="external text" href="http://www.jbc.org/cgi/pmidlookup?view=long&amp;pmid=16303764">"The CLN9 protein, a regulator of dihydroceramide synthase"</a>. <i>J. Biol. Chem.</i> <b>281</b> (5): 2784–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.M509483200">10.1074/jbc.M509483200</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16303764">16303764</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=The+CLN9+protein%2C+a+regulator+of+dihydroceramide+synthase&amp;rft.aulast=Schulz+A%2C+Mousallem+T%2C+Venkataramani+M&amp;rft.au=Schulz+A%2C+Mousallem+T%2C+Venkataramani+M&amp;rft.date=February+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16303764&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M509483200&amp;rft_id=info%3Apmid%2F16303764&amp;rft.issue=5&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=2784-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=281" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no9-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-no9_27-0">^</a></b></span> <span class="reference-text">NCBI Entrez Gene: PPT1 [<i>Homo Sapiens</i>] <a rel="nofollow" class="external free" href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=5538&amp;ordinalpos=28&amp;itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum">http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=5538&amp;ordinalpos=28&amp;itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum</a></span></li>
<li id="cite_note-no13-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-no13_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no13_28-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Sharp, J. et al. (1997). "Loci for classical and a variant LINCL map to chromosomes 11p15 and 15q21-23". <i>Hum Mol Gen</i> <b>6</b> (4): 591–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhmg%2F6.4.591">10.1093/hmg/6.4.591</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9097964">9097964</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Loci+for+classical+and+a+variant+LINCL+map+to+chromosomes+11p15+and+15q21-23&amp;rft.aulast=Sharp%2C+J.&amp;rft.au=Sharp%2C+J.&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2F6.4.591&amp;rft_id=info%3Apmid%2F9097964&amp;rft.issue=4&amp;rft.jtitle=Hum+Mol+Gen&amp;rft.pages=591-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no29-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-no29_29-0">^</a></b></span> <span class="reference-text"><a href="/wiki/Mendelian_Inheritance_in_Man" title="Mendelian Inheritance in Man" class="mw-redirect">Online 'Mendelian Inheritance in Man'</a> (OMIM) <a rel="nofollow" class="external text" href="//omim.org/entry/256730">NCL1, CLN1 -256730</a></span></li>
<li id="cite_note-no1-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-no1_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no1_30-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lyly, Annina; Von Schantz, C; Salonen, T; Kopra, O; Saarela, J; Jauhiainen, M; Kyttälä, A; Jalanko, A (2007). <a rel="nofollow" class="external text" href="http://www.biomedcentral.com/1471-2121/8/22">"Glycosylation, transport, and complex formation of PPT1"</a>. <i>BMC Cell Biology</i> <b>8</b>: 22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1471-2121-8-22">10.1186/1471-2121-8-22</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1906764">1906764</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17565660">17565660</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Glycosylation%2C+transport%2C+and+complex+formation+of+PPT1&amp;rft.au=Jalanko%2C+A&amp;rft.au=Jauhiainen%2C+M&amp;rft.au=Kopra%2C+O&amp;rft.au=Kytt%C3%A4l%C3%A4%2C+A&amp;rft.aulast=Lyly%2C+Annina&amp;rft.au=Lyly%2C+Annina&amp;rft.au=Saarela%2C+J&amp;rft.au=Salonen%2C+T&amp;rft.au=Von+Schantz%2C+C&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.biomedcentral.com%2F1471-2121%2F8%2F22&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2121-8-22&amp;rft_id=info%3Apmc%2F1906764&amp;rft_id=info%3Apmid%2F17565660&amp;rft.jtitle=BMC+Cell+Biology&amp;rft.pages=22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-no20-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-no20_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-no20_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">"NCL/Batten disease: the lysosomal proteinoses". <i>Mol Psychiatry</i>: 434–6. 2002. <q>Two mutations common to this gene are a G to C <a href="/wiki/Transversion" title="Transversion">transversion</a> and a C to T <a href="/wiki/Transition_(genetics)" title="Transition (genetics)">transition</a>, which prematurely terminate <a href="/wiki/Translation_(genetics)" title="Translation (genetics)" class="mw-redirect">translation</a> at <a href="/wiki/Amino_acid" title="Amino acid">amino acid</a> 208 of 563 (7). The deficiency of this lysosomal <a href="/wiki/Protease" title="Protease">protease</a>, then, results in increased <a href="/wiki/ATP_synthase_subunit_C" title="ATP synthase subunit C">subunit C</a> storage.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=NCL%2FBatten+disease%3A+the+lysosomal+proteinoses&amp;rft.date=2002&amp;rft.genre=article&amp;rft.jtitle=Mol+Psychiatry&amp;rft.pages=434-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-no8-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-no8_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gao, H. et al. (2002). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC384912">"Mutations in a novel CLN6-encoded transmembrane cause variant NCL in man and mouse"</a>. <i>American Journal of Human Genetics</i> <b>70</b> (2): 324–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1086%2F338190">10.1086/338190</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC384912">384912</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11791207">11791207</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Mutations+in+a+novel+CLN6-encoded+transmembrane+cause+variant+NCL+in+man+and+mouse&amp;rft.au=Gao%2C+H.&amp;rft.aulast=Gao%2C+H.&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC384912&amp;rft_id=info%3Adoi%2F10.1086%2F338190&amp;rft_id=info%3Apmc%2F384912&amp;rft_id=info%3Apmid%2F11791207&amp;rft.issue=2&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.pages=324-35&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=70" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-no16-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-no16_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fossale, E. et al. <a rel="nofollow" class="external text" href="http://www.biomedc-entral.com/1471-2202/5/57">"Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile ceroid lipofuscinosis"</a>. <i>BMC Neuroscience</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Membrane+trafficking+and+mitochondrial+abnormalities+precede+subunit+c+deposition+in+a+cerebellar+cell+model+of+juvenile+ceroid+lipofuscinosis&amp;rft.au=Fossale%2C+E.&amp;rft.aulast=Fossale%2C+E.&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.biomedc-entral.com%2F1471-2202%2F5%2F57&amp;rft.jtitle=BMC+Neuroscience&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Benitez2011-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-Benitez2011_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Benitez BA, Alvarado D, Cai Y, Mayo K, Chakraverty S, Norton J, Morris JC, Sands MS, Goate A et al. (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3208569">"Exome-sequencing confirms DNAJC5 mutations as cause of Adult Neuronal Ceroid-Lipofuscinosis"</a>. <i>PLoS ONE</i> <b>6</b> (11): e26741. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0026741">10.1371/journal.pone.0026741</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3208569">3208569</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22073189">22073189</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Exome-sequencing+confirms+DNAJC5+mutations+as+cause+of+Adult+Neuronal+Ceroid-Lipofuscinosis&amp;rft.au=Benitez+BA%2C+Alvarado+D%2C+Cai+Y%2C+Mayo+K%2C+Chakraverty+S%2C+Norton+J%2C+Morris+JC%2C+Sands+MS%2C+Goate+A&amp;rft.aulast=Benitez+BA%2C+Alvarado+D%2C+Cai+Y%2C+Mayo+K%2C+Chakraverty+S%2C+Norton+J%2C+Morris+JC%2C+Sands+MS%2C+Goate+A&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3208569&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0026741&amp;rft_id=info%3Apmc%2F3208569&amp;rft_id=info%3Apmid%2F22073189&amp;rft.issue=11&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e26741&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Noskova2011-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Noskova2011_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Noskova L, Stranecky V, Hartmannova H, Pristoupilova A, Baresova V, Ivanek R, Hulkova H, Jahnova H, van der Zee J et al. (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3155175">"Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis"</a>. <i>American Journal of Human Genetics</i> <b>89</b> (241–252): 2011. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ajhg.2011.07.003">10.1016/j.ajhg.2011.07.003</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3155175">3155175</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21820099">21820099</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Mutations+in+DNAJC5%2C+encoding+cysteine-string+protein+alpha%2C+cause+autosomal-dominant+adult-onset+neuronal+ceroid+lipofuscinosis&amp;rft.aulast=Noskova+L%2C+Stranecky+V%2C+Hartmannova+H%2C+Pristoupilova+A%2C+Baresova+V%2C+Ivanek+R%2C+Hulkova+H%2C+Jahnova+H%2C+van+der+Zee+J&amp;rft.au=Noskova+L%2C+Stranecky+V%2C+Hartmannova+H%2C+Pristoupilova+A%2C+Baresova+V%2C+Ivanek+R%2C+Hulkova+H%2C+Jahnova+H%2C+van+der+Zee+J&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3155175&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ajhg.2011.07.003&amp;rft_id=info%3Apmc%2F3155175&amp;rft_id=info%3Apmid%2F21820099&amp;rft.issue=241%E2%80%93252&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.pages=2011&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-urleMedicine_-_Neuronal_Ceroid_Lipofuscinoses_:_Article_by_Celia_H_Chang-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-urleMedicine_-_Neuronal_Ceroid_Lipofuscinoses_:_Article_by_Celia_H_Chang_36-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic498.htm#section~Introduction">"eMedicine – Neuronal Ceroid Lipofuscinoses&#160;: Article by Celia H Chang"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=eMedicine+%E2%80%93+Neuronal+Ceroid+Lipofuscinoses+%3A+Article+by+Celia+H+Chang&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.emedicine.com%2Fneuro%2Ftopic498.htm%23section~Introduction&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid1609834-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid1609834_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Claussen M, Heim P, Knispel J, Goebel HH, Kohlschütter A (Feb 1992). "Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders". <i>American Journal of Medical Genetics</i> <b>42</b> (4): 536–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fajmg.1320420422">10.1002/ajmg.1320420422</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1609834">1609834</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Incidence+of+neuronal+ceroid-lipofuscinoses+in+West+Germany%3A+variation+of+a+method+for+studying+autosomal+recessive+disorders&amp;rft.au=Claussen+M%2C+Heim+P%2C+Knispel+J%2C+Goebel+HH%2C+Kohlsch%C3%BCtter+A&amp;rft.aulast=Claussen+M%2C+Heim+P%2C+Knispel+J%2C+Goebel+HH%2C+Kohlsch%C3%BCtter+A&amp;rft.date=Feb+1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fajmg.1320420422&amp;rft_id=info%3Apmid%2F1609834&amp;rft.issue=4&amp;rft.jtitle=American+Journal+of+Medical+Genetics&amp;rft.pages=536-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid7668318-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7668318_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cardona F, Rosati E (Jun 1995). "Neuronal ceroid-lipofuscinoses in Italy: an epidemiological study". <i>American Journal of Medical Genetics</i> <b>57</b> (2): 142–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fajmg.1320570206">10.1002/ajmg.1320570206</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7668318">7668318</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Neuronal+ceroid-lipofuscinoses+in+Italy%3A+an+epidemiological+study&amp;rft.au=Cardona+F%2C+Rosati+E&amp;rft.aulast=Cardona+F%2C+Rosati+E&amp;rft.date=Jun+1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fajmg.1320570206&amp;rft_id=info%3Apmid%2F7668318&amp;rft.issue=2&amp;rft.jtitle=American+Journal+of+Medical+Genetics&amp;rft.pages=142-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=57" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17092455-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17092455_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Augestad LB, Flanders WD (Nov 2006). "Occurrence of and mortality from childhood neuronal ceroid lipofuscinoses in norway". <i>J. Child Neurol.</i> <b>21</b> (11): 917–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1177%2F08830738060210110801">10.1177/08830738060210110801</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17092455">17092455</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Occurrence+of+and+mortality+from+childhood+neuronal+ceroid+lipofuscinoses+in+norway&amp;rft.au=Augestad+LB%2C+Flanders+WD&amp;rft.aulast=Augestad+LB%2C+Flanders+WD&amp;rft.date=Nov+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F08830738060210110801&amp;rft_id=info%3Apmid%2F17092455&amp;rft.issue=11&amp;rft.jtitle=J.+Child+Neurol.&amp;rft.pages=917-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-safety_study-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-safety_study_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-safety_study_40-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT00151216?term=batten+disease&amp;rank=5">"Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis"</a>. National Institutes of Health<span class="reference-accessdate">. Retrieved <span class="nowrap">16 December</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=Safety+Study+of+a+Gene+Transfer+Vector+for+Children+With+Late+Infantile+Neuronal+Ceroid+Lipofuscinosis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00151216%3Fterm%3Dbatten%2Bdisease%26rank%3D5&amp;rft.pub=National+Institutes+of+Health&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlNathans_Battle_.7C_Clinical_Trial_Efforts-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlNathans_Battle_.7C_Clinical_Trial_Efforts_41-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nathansbattle.com/scientific/clinical.html">"Nathan's Battle – Clinical Trial Efforts"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=Nathan%27s+Battle+%E2%80%93+Clinical+Trial+Efforts&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nathansbattle.com%2Fscientific%2Fclinical.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation web">Klein, Andrew. <a rel="nofollow" class="external text" href="http://www.news.cornell.edu/stories/May08/wcmc.crystal.batten.html">"Gene therapy trial offers new hope for Batten disease, a fatal neurological disease in children"</a>. <i>Cornell Chronicle</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 30,</span> 2008</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Gene+therapy+trial+offers+new+hope+for+Batten+disease%2C+a+fatal+neurological+disease+in+children&amp;rft.aufirst=Andrew&amp;rft.au=Klein%2C+Andrew&amp;rft.aulast=Klein&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.news.cornell.edu%2Fstories%2FMay08%2Fwcmc.crystal.batten.html&amp;rft.jtitle=Cornell+Chronicle&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-safety_study_Rh.10-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-safety_study_Rh.10_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-safety_study_Rh.10_43-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-safety_study_Rh.10_43-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT01161576?term=batten+disease&amp;rank=3">"Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis"</a>. National Institutes of Health<span class="reference-accessdate">. Retrieved <span class="nowrap">16 December</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=Safety+Study+of+a+Gene+Transfer+Vector+%28Rh.10%29+for+Children+With+Late+Infantile+Neuronal+Ceroid+Lipofuscinosis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01161576%3Fterm%3Dbatten%2Bdisease%26rank%3D3&amp;rft.pub=National+Institutes+of+Health&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT01414985?term=batten+disease&amp;rank=2">"AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis With Uncommon Genotypes or Moderate/Severe Impairment"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">16 December</span> 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=AAVRh.10+Administered+to+Children+With+Late+Infantile+Neuronal+Ceroid+Lipofuscinosis+With+Uncommon+Genotypes+or+Moderate%2FSevere+Impairment&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01414985%3Fterm%3Dbatten%2Bdisease%26rank%3D2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11921051-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11921051_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dhar S, Bitting RL, Rylova SN et al. (Apr 2002). "Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons". <i>Annals of Neurology</i> <b>51</b> (4): 448–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fana.10143">10.1002/ana.10143</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11921051">11921051</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Flupirtine+blocks+apoptosis+in+batten+patient+lymphoblasts+and+in+human+postmitotic+CLN3-+and+CLN2-deficient+neurons&amp;rft.au=Dhar+S%2C+Bitting+RL%2C+Rylova+SN&amp;rft.aulast=Dhar+S%2C+Bitting+RL%2C+Rylova+SN&amp;rft.date=Apr+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fana.10143&amp;rft_id=info%3Apmid%2F11921051&amp;rft.issue=4&amp;rft.jtitle=Annals+of+Neurology&amp;rft.pages=448-66&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-urlStudy_of_the_Safety_and_Preliminary_Effectiveness_of_Human_Central_Nervous_System_.28CNS.29_Stem_Cells_.28HuCNS-SC.29_in_Patients_With_Infantile_or_Late_Infantile_Neuronal_Ceroid_Lipofuscinosis_.28NCL.29_-_Full_Text_View_-_ClinicalTrials.gov-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlStudy_of_the_Safety_and_Preliminary_Effectiveness_of_Human_Central_Nervous_System_.28CNS.29_Stem_Cells_.28HuCNS-SC.29_in_Patients_With_Infantile_or_Late_Infantile_Neuronal_Ceroid_Lipofuscinosis_.28NCL.29_-_Full_Text_View_-_ClinicalTrials.gov_46-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT00337636">"Study of the Safety and Preliminary Effectiveness of Human Central Nervous System (CNS) Stem Cells (HuCNS-SC) in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL) - Full Text View - ClinicalTrials.gov"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=Study+of+the+Safety+and+Preliminary+Effectiveness+of+Human+Central+Nervous+System+%28CNS%29+Stem+Cells+%28HuCNS-SC%29+in+Patients+With+Infantile+or+Late+Infantile+Neuronal+Ceroid+Lipofuscinosis+%28NCL%29+-+Full+Text+View+-+ClinicalTrials.gov&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00337636&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11673581-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11673581_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lönnqvist T, Vanhanen SL, Vettenranta K et al. (Oct 2001). <a rel="nofollow" class="external text" href="http://www.neurology.org/cgi/pmidlookup?view=long&amp;pmid=11673581">"Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis"</a>. <i>Neurology</i> <b>57</b> (8): 1411–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1212%2Fwnl.57.8.1411">10.1212/wnl.57.8.1411</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11673581">11673581</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.atitle=Hematopoietic+stem+cell+transplantation+in+infantile+neuronal+ceroid+lipofuscinosis&amp;rft.aulast=L%C3%B6nnqvist+T%2C+Vanhanen+SL%2C+Vettenranta+K&amp;rft.au=L%C3%B6nnqvist+T%2C+Vanhanen+SL%2C+Vettenranta+K&amp;rft.date=Oct+2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11673581&amp;rft_id=info%3Adoi%2F10.1212%2Fwnl.57.8.1411&amp;rft_id=info%3Apmid%2F11673581&amp;rft.issue=8&amp;rft.jtitle=Neurology&amp;rft.pages=1411-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=57" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-urlBDSRA_-_Batten_Disease_Support_and_Research_Association-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlBDSRA_-_Batten_Disease_Support_and_Research_Association_48-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bdsra.org/research/Pearce-trial.htm">"BDSRA – Batten Disease Support and Research Association"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuronal+ceroid+lipofuscinosis&amp;rft.btitle=BDSRA+%E2%80%93+Batten+Disease+Support+and+Research+Association&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bdsra.org%2Fresearch%2FPearce-trial.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit&amp;section=22" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK1428/">GeneReviews/NCBI/NIH/UW entry on Neuronal ceroid-Lipofuscinosis</a></li>
<li><a rel="nofollow" class="external text" href="http://bdsra.org/whatis.html">Batten Disease General Information Page</a></li>
<li><a rel="nofollow" class="external text" href="http://www.genetests.org/profiles/ncl">GeneReviews: Neuronal ceroid lipofuscinosis</a></li>
<li><a rel="nofollow" class="external text" href="http://www.hideandseek.org/">Hide and Seek Foundation For Lysosomal Disease Research</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lipid_storage_disorders" title="Template:Lipid storage disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lipid_storage_disorders" title="Template talk:Lipid storage disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lipid_storage_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">(<a href="/wiki/Lysosomal_storage_disease" title="Lysosomal storage disease">LSD</a>) <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_error_of_lipid_metabolism" title="Inborn error of lipid metabolism">lipid metabolism</a>: <a href="/wiki/Lipid_storage_disorder" title="Lipid storage disorder">lipid storage disorders</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E75.29_Lipids" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E75</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Other_metabolic_and_immunity_disorders_.28270.E2.80.93279.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">272.7–272.8</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Sphingolipidoses" title="Sphingolipidoses">Sphingolipidoses</a><br />
(to <a href="/wiki/Ceramide" title="Ceramide">ceramide</a>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">From <a href="/wiki/Ganglioside" title="Ganglioside">ganglioside</a><br />
(<a href="/wiki/Gangliosidosis" title="Gangliosidosis">gangliosidoses</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ganglioside" title="Ganglioside">Ganglioside</a>: <a href="/wiki/GM1_gangliosidoses" title="GM1 gangliosidoses">GM1 gangliosidoses</a></li>
<li><a href="/wiki/GM2_gangliosidoses" title="GM2 gangliosidoses">GM2 gangliosidoses</a> (<a href="/wiki/Sandhoff_disease" title="Sandhoff disease">Sandhoff disease</a></li>
<li><a href="/wiki/Tay%E2%80%93Sachs_disease" title="Tay–Sachs disease">Tay–Sachs disease</a></li>
<li><a href="/wiki/GM2-gangliosidosis,_AB_variant" title="GM2-gangliosidosis, AB variant">AB variant</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">From <a href="/wiki/Globoside" title="Globoside">globoside</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Globotriaosylceramide" title="Globotriaosylceramide">Globotriaosylceramide</a>: <a href="/wiki/Fabry_disease" title="Fabry disease">Fabry's disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">From <a href="/wiki/Sphingomyelin" title="Sphingomyelin">sphingomyelin</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sphingomyelin" title="Sphingomyelin">Sphingomyelin</a>: <i>phospholipid:</i> <a href="/wiki/Niemann%E2%80%93Pick_disease" title="Niemann–Pick disease">Niemann–Pick disease</a> (<a href="/wiki/Niemann%E2%80%93Pick_disease,_SMPD1-associated" title="Niemann–Pick disease, SMPD1-associated">SMPD1-associated</a></li>
<li><a href="/wiki/Niemann%E2%80%93Pick_disease,_type_C" title="Niemann–Pick disease, type C">type C</a>)</li>
<li><a href="/wiki/Glucocerebroside" title="Glucocerebroside">Glucocerebroside</a>: <a href="/wiki/Gaucher%27s_disease" title="Gaucher's disease">Gaucher's disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">From <a href="/wiki/Sulfatide" title="Sulfatide">sulfatide</a><br />
(<a href="/wiki/Sulfatidosis" title="Sulfatidosis">sulfatidoses</a>
<ul>
<li><a href="/wiki/Leukodystrophy" title="Leukodystrophy">leukodystrophy</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sulfatide" title="Sulfatide">Sulfatide</a>: <a href="/wiki/Metachromatic_leukodystrophy" title="Metachromatic leukodystrophy">Metachromatic leukodystrophy</a></li>
<li><a href="/wiki/Multiple_sulfatase_deficiency" title="Multiple sulfatase deficiency">Multiple sulfatase deficiency</a></li>
<li><a href="/wiki/Galactocerebroside" title="Galactocerebroside">Galactocerebroside</a>: <a href="/wiki/Krabbe_disease" title="Krabbe disease">Krabbe disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">To <a href="/wiki/Sphingosine" title="Sphingosine">sphingosine</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ceramide" title="Ceramide">Ceramide</a>: <a href="/wiki/Farber_disease" title="Farber disease">Farber disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><strong class="selflink">NCL</strong></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Infantile_neuronal_ceroid_lipofuscinosis" title="Infantile neuronal ceroid lipofuscinosis">Infantile</a></li>
<li><a href="/wiki/Jansky%E2%80%93Bielschowsky_disease" title="Jansky–Bielschowsky disease">Jansky–Bielschowsky disease</a></li>
<li><a href="/wiki/Batten_disease" title="Batten disease">Batten disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cerebrotendineous_xanthomatosis" title="Cerebrotendineous xanthomatosis">Cerebrotendineous xanthomatosis</a></li>
<li><a href="/wiki/Cholesteryl_ester_storage_disease" title="Cholesteryl ester storage disease">Cholesteryl ester storage disease</a> (<a href="/wiki/Lysosomal_acid_lipase_deficiency" title="Lysosomal acid lipase deficiency">Lysosomal acid lipase deficiency</a>/<a href="/wiki/Wolman_disease" title="Wolman disease">Wolman disease</a>)</li>
<li><a href="/wiki/Sea-blue_histiocytosis" title="Sea-blue histiocytosis">Sea-blue histiocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1054
CPU time usage: 0.594 seconds
Real time usage: 0.890 seconds
Preprocessor visited node count: 3080/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 136091/2097152 bytes
Template argument size: 1199/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 1/500
Lua time usage: 0.220/10.000 seconds
Lua memory usage: 3.85 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  774.848      1 - -total
 39.84%  308.710      1 - Template:Reflist
 33.49%  259.498      1 - Template:Citation_needed
 32.67%  253.120      1 - Template:Fix
 32.14%  249.059      2 - Template:Category_handler
 20.95%  162.296     32 - Template:Cite_journal
 11.67%   90.450      1 - Template:Infobox_disease
 10.05%   77.861      1 - Template:Infobox
  6.04%   46.772      1 - Template:Lipid_storage_disorders
  5.68%   44.035      3 - Template:Navbox
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:2187652-0!*!0!!en!*!* and timestamp 20150711152624 and revision id 667672442
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;oldid=667672442#Forms">https://en.wikipedia.org/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;oldid=667672442#Forms</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Lipid_storage_disorders" title="Category:Lipid storage disorders">Lipid storage disorders</a></li><li><a href="/wiki/Category:Rare_diseases" title="Category:Rare diseases">Rare diseases</a></li><li><a href="/wiki/Category:Autosomal_recessive_disorders" title="Category:Autosomal recessive disorders">Autosomal recessive disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:CS1_Norwegian-language_sources_(no)" title="Category:CS1 Norwegian-language sources (no)">CS1 Norwegian-language sources (no)</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_November_2008" title="Category:Articles with unsourced statements from November 2008">Articles with unsourced statements from November 2008</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuronal+ceroid+lipofuscinosis&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuronal+ceroid+lipofuscinosis" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Neuronal_ceroid_lipofuscinosis"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Neuronal_ceroid_lipofuscinosis"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Neuronal_ceroid_lipofuscinosis" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Neuronal_ceroid_lipofuscinosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Neuronal_ceroid_lipofuscinosis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;oldid=667672442" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q4358039" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Neuronal_ceroid_lipofuscinosis&amp;id=667672442" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Neuronal+ceroid+lipofuscinosis">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Neuronal+ceroid+lipofuscinosis&amp;oldid=667672442&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Neuronale_Ceroid-Lipofuszinose" title="Neuronale Ceroid-Lipofuszinose – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Ceroidolipofuscinosis" title="Ceroidolipofuscinosis – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%84%DB%8C%D9%BE%D9%88%D9%81%D9%88%D8%B4%DB%8C%D9%86%D9%88%D8%B2_%D8%B3%D8%B1%D9%88%D8%A6%DB%8C%D8%AF_%D9%86%D9%88%D8%B1%D9%88%D9%86%DB%8C" title="لیپوفوشینوز سروئید نورونی – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/C%C3%A9ro%C3%AFdes-lipofuscinoses_neuronales" title="Céroïdes-lipofuscinoses neuronales – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Lipeafuiscion%C3%B3is%C3%AD_C%C3%A9iri%C3%BAla_N%C3%A9ar%C3%B3nacha" title="Lipeafuiscionóisí Céiriúla Néarónacha – Irish" lang="ga" hreflang="ga">Gaeilge</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Ceroidolipofuscynozy_neuronalne" title="Ceroidolipofuscynozy neuronalne – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-ru badge-Q17437798 badge-goodarticle" title="good article"><a href="//ru.wikipedia.org/wiki/%D0%92%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D0%B8%D0%B4%D0%BD%D1%8B%D0%B5_%D0%BB%D0%B8%D0%BF%D0%BE%D1%84%D1%83%D1%81%D1%86%D0%B8%D0%BD%D0%BE%D0%B7%D1%8B_%D0%BD%D0%B5%D0%B9%D1%80%D0%BE%D0%BD%D0%BE%D0%B2" title="Восковидные липофусцинозы нейронов – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Neuronaalinen_seroidilipofuskinoosi" title="Neuronaalinen seroidilipofuskinoosi – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q4358039#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 19 June 2015, at 19:49.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Neuronal_ceroid_lipofuscinosis&amp;mobileaction=toggle_view_mobile#Forms" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":101,"wgHostname":"mw1100"});
}</script>
	</body>
</html>
